Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas
NCT ID: NCT01584752
Last Updated: 2019-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
60 participants
OBSERVATIONAL
2011-11-30
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of GORE® BIO-A® Fistula Plug for Use in Anal Fistula Repair
NCT01290666
Efficacy of an Anorectal Fistula Plug With Sealing of the Internal Opening as a Treatment for Perianal Fistula
NCT03381365
Long-term Follow-up of Anal Fistula Plug
NCT03961984
Anal Fistula Plug, a Retrospective Study
NCT04319861
Success Rate, Continence, and Quality of Life With a Bioprosthetic Plug for Treating Complex Anal Fistula
NCT01612195
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fistula patients
Gore-BioA Fistula Plug
Gore-BioA Fistula Plug
Gore-BioA Fistula Plug
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gore-BioA Fistula Plug
Gore-BioA Fistula Plug
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* High cryptoglandular perianal fistula
* Written approval for the study
* Sufficient co-operation for the study
* Localization of the fistula by ultrasound or MRI
Exclusion Criteria
* Immunosuppressive treatment
* Anovaginal fistula
* Radiation therapy 6 months before study
* Chemotherapy 6 months before study
* Low- or intersphincteric fistula
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Finland Hospital District
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matti V Kairaluoma, ph.D
Role: STUDY_DIRECTOR
Central Hospital, Jyväskylä, Finland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsinki University Hospital
Helsinki, , Finland
Central Hospital
Joensuu, , Finland
Central Hospital
Jyväskylä, , Finland
Central Hospital
Lahti, , Finland
Oulu University Hospital
Oulu, , Finland
Central Hospital
Seinäjoki, , Finland
Turku University Hospital
Turku, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KSSHP1U/2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.